Cetera Advisor Networks’s Palvella Therapeutics PVLA Stock Holding History

Cetera Advisor Networks’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-177	Closed	-$56K	–	1291
2019 Q4	$56K	Sell	177 -33	-16%	-$9.15K	﹤0.01%	1221
2019 Q3	$64K	Hold	210	–	–	﹤0.01%	1168
2019 Q2	$72K	Hold	210	–	–	﹤0.01%	1162
2019 Q1	$64K	Hold	210	–	–	﹤0.01%	1125
2018 Q4	$39K	Sell	210 -12	-5%	-$3.72K	﹤0.01%	1021
2018 Q3	$104K	Sell	222 -19	-8%	-$8.26K	﹤0.01%	1103
2018 Q2	$109K	Hold	241	–	–	0.01%	818
2018 Q1	$121K	Buy	241 +50	+26%	+$30.9K	0.01%	825
2017 Q4	$124K	Buy	+191	New	+$88.8K	0.01%	959

Other funds holding PVLA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cetera Advisor Networks's PVLA Position: Q1 2020 in Review

Cetera Advisor Networks sold out of Palvella Therapeutics (PVLA) in Q1 2020, closing a stake of 177 shares — an estimated $56K sold.

Cetera Advisor Networks first reported a position in PVLA in Q4 2017 and held it in 9 quarters. The position peaked at $124K in Q4 2017. 95 funds tracked by Wall St. Rank hold PVLA as of Q1 2020.

Cetera Advisor Networks reported no remaining Palvella Therapeutics position as of Q1 2020 after selling out during the quarter.
Cetera Advisor Networks sold 177 Palvella Therapeutics shares in Q1 2020, an estimated $56K.
Cetera Advisor Networks first reported a position in Palvella Therapeutics in Q4 2017 and held it in 9 quarters.
Cetera Advisor Networks's Palvella Therapeutics position peaked at $124K in Q4 2017.
95 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2020.

Based on Cetera Advisor Networks's 13F filing for Q1 2020, filed 8 May 2020.